Carbios, (Euronext Growth Paris : ALCRB), a pioneer in the development and industrialization of biological technologies to reinvent the life cycle of plastic and textiles, and Selenis, a leading supplier of high-quality specialty polyester solutions, have signed a Letter of Intent (LOI) to cooperate in the production of PETG1.
By leveraging Carbios’ unique enzymatic depolymerization technology and Selenis’ expertise in polymerization, the companies aim to develop a premium, sustainable PETG material made from PET waste for the Cosmetic and Healthcare packaging sectors across Europe and the U.S. This partnership follows a two-year collaboration between the two companies and represents a significant advancement in the plastic recycling industry.
PETG is an indispensable packaging material in both the cosmetics and healthcare industries due to its exceptional clarity, durability, mechanical and chemical resistance. CARBIOS’ enzymatic depolymerization solution breaks down all types of PET waste into PTA2 and MEG3 monomers, which are then transformed into PETG through Selenis’ advanced polymerization processes. Thanks to the purity of these monomers, PETG issued from biorecycling presents the exact same properties as virgin PETG, allowing for products packaged in thick, molded pots and lids to be protected and presented attractively. In the medical and pharmaceutical industries, PETG properties are also critical for guaranteeing top packaging performance, sterility, transparency and optical brightness, making it an ideal choice for complex medical device packaging, pharmaceuticals blisters, or any other packaging of diagnostic equipment. The material’s value is therefore further underscored by combining a sustainable recycling solution whilst guaranteeing all needed properties, aligning with consumer sustainability demands and stringent regulatory requirements.
PETG is an indispensable packaging material in both the cosmetics and healthcare industries due to its exceptional clarity, durability, mechanical and chemical resistance. CARBIOS’ enzymatic depolymerization solution breaks down all types of PET waste into PTA2 and MEG3 monomers, which are then transformed into PETG through Selenis’ advanced polymerization processes. Thanks to the purity of these monomers, PETG issued from biorecycling presents the exact same properties as virgin PETG, allowing for products packaged in thick, molded pots and lids to be protected and presented attractively. In the medical and pharmaceutical industries, PETG properties are also critical for guaranteeing top packaging performance, sterility, transparency and optical brightness, making it an ideal choice for complex medical device packaging, pharmaceuticals blisters, or any other packaging of diagnostic equipment. The material’s value is therefore further underscored by combining a sustainable recycling solution whilst guaranteeing all needed properties, aligning with consumer sustainability demands and stringent regulatory requirements.
CARBIOS and Selenis’ partnership is the result of extensive pilot and industrial polymerization trials that have refined the quality of the end product. The result is high-specialty PETG grades issued from biorecycling that meet the strict requirements of sectors like cosmetics and healthcare, where Selenis has a strong presence through its Selcare brand.
Emmanuel Ladent, CEO of CARBIOS: “CARBIOS and Selenis have a long collaboration, and we are pleased to build on this established relationship to produce PETG issued from CARBIOS’ unique biorecycling technology. This high-specialty, premium material meets demanding quality requirements whilst also contributing to the transition to more sustainable packaging materials. The partnership will open new markets for CARBIOS, notably the healthcare sector, as we continue our worldwide commercial deployment.”
Eduardo Santos, Head of Corporate Strategy at Selenis: “This collaboration marks an exciting step in our mission to drive sustainability in the polymerization industry. By combining our 65 years of expertise with CARBIOS’ pioneering biorecycling technology that ensures high-quality monomers for the production of virgin-like PETG, we are advancing in the development of sustainable materials to meet the growing demand for environmentally responsible solutions in the cosmetic and healthcare sectors. Together, we have the potential to reshape the future of sustainable plastics."
Carbios is a biotech company developing and industrializing biological solutions to reinvent the life cycle of plastic and textiles. Inspired by nature, Carbios develops enzyme-based processes to break down plastic with a mission to avoid plastic and textile pollution, and accelerate the transition to a circular economy. Its two disruptive technologies for the biorecycling of PET and the biodegradation of PLA are reaching industrial and commercial scale. Its biorecycling demonstration plant has been operational since 2021 and a first industrial plant, in partnership with Indorama Ventures, is currently under construction. Carbios, founded in 2011 by Truffle Capital, has received scientific recognition, notably with the cover of Nature, and is supported by prestigious brands in the cosmetics, Food & Beverage and apparel industries to enhance their products’ recyclability and circularity. Nestlé Waters, PepsiCo and Suntory Beverage & Food Europe are members of a packaging consortium founded by Carbios and L’Oréal. On, Patagonia, Puma, PVH Corp. and Salomon collaborate with Carbios in a textile consortium.
Visit www.carbios.com/en to find out more about biotechnology powering plastic and textile circularity.
For latest news and media assets, visit Carbios newsroom: www.carbios.com/newsroom/en/
ISIN Code FR0011648716
Ticker Code Euronext Growth: ALCRB
LEI: 969500M2RCIWO4NO5F08
Carbios is eligible for the PEA-PME, a government program allowing French residents investing in SMEs to benefit from income tax rebates.
Be sure to consult us for further details on our products features and possibilities tailored to your requirements.
Contact us
